Definium Therapeutics, Inc. (DFTX)

NASDAQ: DFTX · Real-Time Price · USD

35.67

-0.33 (-0.92%)

At close: Oct 23, 2026, 4:00 PM EDT

35.72

+0.05 (0.15%)

After-hours: Oct 23, 2026, 7:57 PM EDT

Definium Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	655.27	257.84	273.74	99.7	142.14	133.54
Short-Term Investments	428.61	153.76	-	-	-	-
Cash & Short-Term Investments	1,084	411.59	273.74	99.7	142.14	133.54
Cash Growth	492.31%	50.36%	174.55%	-29.86%	6.44%	66.73%
Prepaid Expenses	8.22	7.73	7.88	4.17	3.91	3.68
Total Current Assets	1,092	419.32	281.62	103.87	146.06	137.22
Goodwill	19.92	19.92	19.92	19.92	19.92	19.92
Other Intangible Assets	-	-	-	0.53	3.69	6.87
Other Long-Term Assets	0.88	0.86	0.61	0.22	0.33	-
Total Assets	1,113	440.1	302.15	124.54	169.99	164

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	6.97	5.35	2.01	4.14	2.11	4.18
Accrued Expenses	37.22	20.45	12.83	11.63	5.88	6.23
Other Current Liabilities	113.02	40.91	24.01	16.48	9.9	-
Total Current Liabilities	157.2	66.7	38.85	32.25	17.89	10.41
Long-Term Debt	36.47	40.58	21.85	14.13	-	-
Other Long-Term Liabilities	0.55	0.5	-	0.03	1.18	1.93
Total Liabilities	194.22	107.77	60.7	46.41	19.08	12.34

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Additional Paid-In Capital	1,737	913.91	639.51	367.99	344.76	288.29
Retained Earnings	-818.76	-582.67	-398.88	-290.2	-194.47	-137.67
Comprehensive Income & Other	0.42	1.09	0.82	0.34	0.63	1.05
Shareholders' Equity	918.68	332.33	241.45	78.13	150.92	151.66
Total Liabilities & Equity	1,113	440.1	302.15	124.54	169.99	164

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	36.47	40.58	21.85	14.13	-	-
Net Cash (Debt)	1,047	371.01	251.89	85.58	142.14	133.54
Net Cash Growth	641.78%	47.29%	194.35%	-39.80%	6.44%	66.73%
Net Cash Per Share	10.31	4.15	3.57	2.19	4.61	4.88
Filing Date Shares Outstanding	134.37	99.7	75.37	41.33	38.06	28.58
Total Common Shares Outstanding	134.37	98.78	75.1	41.1	37.98	28.55
Working Capital	934.9	352.62	242.77	71.63	128.16	126.81
Book Value Per Share	6.84	3.36	3.21	1.90	3.97	5.31
Tangible Book Value	898.76	312.41	221.53	57.69	127.31	124.88
Tangible Book Value Per Share	6.69	3.16	2.95	1.40	3.35	4.37